DEVELOPMENT OF OPTICAL NANOTHERMOMETERS FOR MEDICAL APPLICATIONS
医疗应用光学纳米温度计的开发
基本信息
- 批准号:7875648
- 负责人:
- 金额:$ 19.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdverse effectsAmino AcidsAnimalsApplications GrantsBiological ModelsBiomedical TechnologyBody TemperatureCell SurvivalCellsDevelopmentDiagnosticDyesEnsureExcisionFluorescenceFluorescent DyesFocused Ultrasound TherapyFoundationsGoalsGoldHandHeatingHigh temperature of physical objectInjuryLasersLeadLifeLightLongitudinal StudiesMapsMedicalMethodsMonitorMusOperative Surgical ProceduresOpticsOrganPenetrationPolyethylene GlycolsProceduresProcessPropertyProstatic NeoplasmsRadiofrequency Interstitial AblationRecurrenceReporterReportingRiskSafetySiteSurfaceTemperatureTestingThermal Ablation TherapyThermometersTissuesbasecancer therapydosagefluorophoreimprovedin vitro testingin vivolight scatteringmeetingsmicrowave electromagnetic radiationnanonanoparticlenanoprobenovelprototypepublic health relevanceradiofrequencytumortumor eradication
项目摘要
DESCRIPTION (provided by applicant): The thermal ablation of tumors, encompassing laser ablation and focused ultrasound and radiofrequency ablation, is an alternative method to overcome the problems associated with open surgery and is founded on destruction of tumors by applying the heat directly to the tumor site. Thermal treatment of tumors, however, is hindered if the tumor is in close proximity to vital organs sensitive to overheating. On the other hand, over-cautious heating results in incomplete tumor eradication and early tumor recurrences. Therefore, control over the heating process is of critical importance to ensure uniform and adequate heating of the tumor. The development of an optically guided method to control and improve thermal ablation constitutes the overall goal of this project. We propose a method of tumor treatment based on thermal ablation enhanced with temperature sensitive nanoparticles (nanothermometers). The principle of temperature sensitivity of the nanothermometers is based on thermally induced fluorescence. At a normal body temperature, the nanoparticles are invisible; upon heating, the nanoparticles generate fluorescence and become visible. Towards our goal, we will synthesize different nanoparticles and optimize their properties. The temperature sensitive nanoparticles will be constructed from non-toxic materials such as gold, near infrared dyes frequently used in diagnostics, and linkers composed from common amino acids or polyethylene glycols. The nanoparticles will be rigorously tested in vitro, in cells, phantoms and in small animals. In the conclusion of the study, the nanoparticles will be delivered to the tumor site and the tumor will be exposed to the thermal energy. We will be using laser ablation as a method of choice for delivering thermal energy. Under laser ablation conditions, the proposed nanoparticles will provide three important functions: i they will report and control the heating process by turning fluorescence "ON" at the desired temperature, ii they will convert light energy to heat, increasing the temperature inside the tumor, and iii they will propagate energy deep into the tumor, thus providing uniform heating. We expect to establish a strong foundation for utilizing thermal ablation in combination with temperature sensitive nanoparticles in the treatment of tumors. The development of such novel biomedical technology would represent a significant advancement in the treatment of cancer.
PUBLIC HEALTH RELEVANCE: The goal of this project is to develop an optically guided thermal ablation method for treatment of tumors using nanothermometers to ensure both uniform and adequate heating of the tumors. These nanothermometers will allow for a higher level of control over the ablation procedure and render the treatment of tumors safer by lowering the chances of tumor recurrences.
描述(由申请人提供):肿瘤热消融,包括激光消融、聚焦超声和射频消融,是克服开放手术相关问题的另一种方法,其基础是通过直接向肿瘤施加热量来破坏肿瘤地点。然而,如果肿瘤靠近对过热敏感的重要器官,那么肿瘤的热治疗就会受到阻碍。另一方面,过度谨慎的加热会导致肿瘤根除不彻底和肿瘤早期复发。因此,控制加热过程对于确保肿瘤的均匀和充分加热至关重要。开发控制和改善热消融的光学引导方法构成了该项目的总体目标。 我们提出了一种基于温度敏感纳米颗粒(纳米温度计)增强热消融的肿瘤治疗方法。纳米温度计的温度灵敏度原理基于热诱导荧光。在正常体温下,纳米颗粒是看不见的;加热后,纳米颗粒会产生荧光并变得可见。为了实现我们的目标,我们将合成不同的纳米颗粒并优化它们的性能。温度敏感纳米颗粒将由无毒材料制成,例如金、诊断中常用的近红外染料以及由常见氨基酸或聚乙二醇组成的连接体。纳米颗粒将在体外、细胞、模型和小动物中进行严格测试。在研究的结论中,纳米颗粒将被输送到肿瘤部位,肿瘤将暴露在热能中。我们将使用激光烧蚀作为传递热能的一种选择方法。在激光消融条件下,所提出的纳米颗粒将提供三个重要功能:i它们将通过在所需温度下“打开”荧光来报告和控制加热过程,ii它们将光能转化为热能,增加肿瘤内的温度, iii 它们会将能量传播到肿瘤深处,从而提供均匀的加热。我们期望为利用热消融与温度敏感纳米粒子结合治疗肿瘤奠定坚实的基础。这种新型生物医学技术的发展将代表癌症治疗的重大进步。
公共健康相关性:该项目的目标是开发一种光学引导热消融方法,使用纳米温度计治疗肿瘤,以确保肿瘤均匀且充分加热。这些纳米温度计将允许对消融过程进行更高水平的控制,并通过降低肿瘤复发的机会使肿瘤治疗更安全。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mikhail Y. Berezin其他文献
Investigating chemotherapy effects on peripheral nerve elasticity
研究化疗对周围神经弹性的影响
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Vsevolod Cheburkanov;Junwei Du;Mikhail Y. Berezin;Vladislav V. Yakovlev - 通讯作者:
Vladislav V. Yakovlev
Mikhail Y. Berezin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mikhail Y. Berezin', 18)}}的其他基金
Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy
使用 AI 增强深紫外拉曼显微镜对骨活检进行分子和细胞成像
- 批准号:
10413606 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy
使用 AI 增强深紫外拉曼显微镜对骨活检进行分子和细胞成像
- 批准号:
10657760 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
基于成像的方法来理解和预测化疗引起的周围神经病变
- 批准号:
9751226 - 财政年份:2017
- 资助金额:
$ 19.27万 - 项目类别:
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
基于成像的方法来理解和预测化疗引起的周围神经病变
- 批准号:
10220889 - 财政年份:2017
- 资助金额:
$ 19.27万 - 项目类别:
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
基于成像的方法来理解和预测化疗引起的周围神经病变
- 批准号:
9981988 - 财政年份:2017
- 资助金额:
$ 19.27万 - 项目类别:
ASSESSMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY WITH ACTIVABLE PROBES
使用可激活探针评估化疗引起的周围神经病变
- 批准号:
8958415 - 财政年份:2015
- 资助金额:
$ 19.27万 - 项目类别:
FLUORESCENCE SPECTROPHOTOMETER IN NIR RANGE FOR BIOLOGICAL AND MEDICAL APPLICATIO
用于生物和医学应用的近红外范围荧光分光光度计
- 批准号:
8052140 - 财政年份:2011
- 资助金额:
$ 19.27万 - 项目类别:
DEVELOPMENT OF OPTICAL NANOTHERMOMETERS FOR MEDICAL APPLICATIONS
医疗应用光学纳米温度计的开发
- 批准号:
8054330 - 财政年份:2010
- 资助金额:
$ 19.27万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
开发细胞穿透性 β-连环蛋白拮抗剂肽作为 Wnt 驱动乳腺癌的候选治疗药物
- 批准号:
10707593 - 财政年份:2021
- 资助金额:
$ 19.27万 - 项目类别:
Validation of a single-pass surgical trajectory to enable AAV2-hAADC infusion into brainstem and mid-brain in nonhuman primate
验证单次手术轨迹,使 AAV2-hAADC 能够输注到非人灵长类动物的脑干和中脑
- 批准号:
10040048 - 财政年份:2020
- 资助金额:
$ 19.27万 - 项目类别:
Development of small molecules for ERG ablation in prostate cancer
开发用于前列腺癌 ERG 消融的小分子
- 批准号:
9191347 - 财政年份:2015
- 资助金额:
$ 19.27万 - 项目类别:
Development of small molecules for ERG ablation in prostate cancer
开发用于前列腺癌 ERG 消融的小分子
- 批准号:
9005588 - 财政年份:2015
- 资助金额:
$ 19.27万 - 项目类别:
Validating novel drug targets in Trypanosoma cruzi polyamine biosynthesis
验证克氏锥虫多胺生物合成中的新药物靶点
- 批准号:
8525512 - 财政年份:2013
- 资助金额:
$ 19.27万 - 项目类别: